Aggrenox - Aggrenox is in a group of drugs called salicylates (sa-LIS-il-ates). It works by reducing substances in the body that cause pain, fever, and inflammation.
Dipyridamole keeps platelets in your blood from sticking together to form clots.
The combination of Aggrenox and dipyridamole is used to reduce the risk of stroke in people who have had blood clots or a "mini-stroke" (also called a transient ischemic attack or TIA).
Aggrenox and dipyridamole may also be used for other purposes not listed in this medication guide.
Aggrenox, a non-nitrate coronary vasodilator that also inhibits platelet aggregation, is combined with other anticoagulant drugs, such as warfarin, to prevent thrombosis in patients with valvular or vascular disorders. Aggrenox is also used in myocardial perfusion imaging, as an antiplatelet agent, and in combination with Aggrenox for stroke prophylaxis.
Indication: For as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.
Reduction of the risk of ischaemic stroke and transient ischaemic attacks.
To reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.
Aggrenox® (aspirin/extended-release dipyridamole) capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.
Indications: thrombosis prophylaxis
Reduce risk of stroke in patients who had transient ischaemia of the brain or completed ischaemic stroke due to thrombosis.
Dipyridamole (also known commercially by Persantine) is a drug that inhibits thrombus formation when given chronically and causes vasodilation when given at high doses over short time.